Research and Markets: Lyme Disease-Pipeline Insights 2015 - Reviews Key Players Involved in the Therapeutics Development for Lyme Disease

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/t9679s/lyme) has announced the addition of the "Lyme Disease-Pipeline Insights" report to their offering.

Summary

Lyme Disease-Pipeline Insights provides the in-depth analysis of the pipeline assets across the Lyme Disease. The main objective of this report is to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Lyme Disease Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

Lyme Disease-Pipeline Insights Report covers the Lyme Disease pipeline molecules at various stages of development like pre-registration phase, clinical phases (Phase III, Phase II & Phase I), pre-clinical and discovery phases. The Report also provides Lyme Disease related therapeutic assessments by molecule type, route of administration, monotherapy and combination products. The Report also highlights the discontinued and inactive projects in pipeline for Lyme Disease.

Scope

  • The report provides a Lyme Disease Landscape across the globe
  • The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology, development partner and chemical information
  • Coverage of the Lyme Disease pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
  • Pipeline products coverage based on various stages of development from NDA filings to discovery.

Key Topics Covered:

  • Lyme Disease Overview
  • Lyme Disease Pipeline Therapeutics
  • Lyme Disease Therapeutics under Development by Companies
  • Lyme Disease Late Stage Products (Filed and Phase III)
  • Comparative Analysis
  • Lyme Disease Mid Clinical Stage Products (Phase II)
  • Comparative Analysis
  • Lyme Disease Early Clinical Stage Products (Phase I and IND Filed)
  • Comparative Analysis
  • Lyme Disease Discovery and Pre-Clinical Stage Products
  • Comparative Analysis
  • Drug Candidate Profiles
  • Lyme Disease - Therapeutics Assessment
  • Assessment by Monotherapy Products
  • Assessment by Combination Products
  • Assessment by Route of Administration
  • Assessment by Molecule Type
  • Lyme Disease - Discontinued Products
  • Lyme Disease - Dormant Products
  • Companies Involved in Therapeutics Development for Lyme Disease

For more information visit http://www.researchandmarkets.com/research/t9679s/lyme

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals